XML 29 R18.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Deficit
 3 Months Ended
Dec. 31, 2020
Stockholders' Equity Note [Abstract]  
Stockholders' Deficit

NOTE 12 – Stockholders' Deficit

 

2021 Private Placement

 

On January 12, 2021, the Company entered into a common stock and warrant purchase agreement with certain accredited investors pursuant to which the Company, in a private placement (the "2021 Private Placement"), agreed to issue and sell an aggregate of 12,500,000 shares of the common stock and warrants to purchase an aggregate of 12,500,000 shares of common stock resulting in total gross proceeds of $12.5 million before deducting placement agent fees and estimated offering expenses. See Note 13 – Subsequent Events.

 

2019 Common Stock Offering

 

On October 23, 2019, the Company entered into Securities Purchase Agreements with certain accredited investors, pursuant to which the Company, in a private placement, has issued and sold 141,666 shares of the Company's common stock to the accredited investors at a price of $1.80 per share, for gross proceeds amounting to $255,000. The Company filed a registration statement with the SEC covering the resale of the shares of common stock sold in the private placement on August 11, 2020.

 

Warrant Activity and Summary

 

The following table summarizes warrant activity during the three month period ended December 31, 2020:

 

       Exercise
Price		   Weighted
Average		   Weighted
Average		 
   Warrants   Per Warrant   Exercise Price   Term (years) 
Outstanding and exercisable at September 30, 2020   10,170,588    $1.80 - 3.00   $2.35    2.89 
Issued   —   $—   $—    — 
Exercised   —   $—   $—    — 
Forfeited   —   $—   $—    — 
Outstanding and exercisable at December 31, 2020   10,170,588    $1.80 - 3.00   $2.35    2.64